REGULATORY ACTION: CDSCO Bans GLP-1 Surrogate Advertising INDIA - March 11 - The Central Drugs Standard Control Organisation issued a strong advisory prohibiting pharmaceutical companies from using "so-called awareness campaigns" to promote GLP-1 drugs
It yields a more bioavailable and effective formula
Additionally, follow-up at 31 weeks showed no difference in eGFR between the placebo and oral-semaglutide groups compared with baseline eGFR measurements, suggesting that treatment had no adverse effects on kidney function
It's a watershed moment for the type 2 diabetes and weight loss industry
KPV is an ultra-short tripeptide derived from alpha-melanocyte stimulating hormone, researched primarily for chronic inflammation, skin disorders, and gut health support
Research about the efficacy and safety of senna was submitted to the FDA, and sennacontaining products were allowed to stay in the OTC category